US EditionPublished • loading... • Updated
SGLT2 Inhibitors Safe, Effective for Diabetes in Elderly
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGSGLT2 Inhibitors Safe, Effective for Diabetes in Elderly
In a groundbreaking multi-center retrospective cohort study published in BMC Geriatrics, researchers have illuminated the nuanced effectiveness and safety profile of sodium-glucose co-transporter 2 inhibitors (SGLT2 inhibitors) in elderly patients aged 75 and older who are grappling with diabetes. This research pioneers a vital understanding of how these relatively novel antidiabetic agents operate within a vulnerable, yet rapidly expanding demo…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
